ASTHMA
Clinical trials for ASTHMA explained in plain language.
Never miss a new study
Get alerted when new ASTHMA trials appear
Sign up with your email to follow new studies for ASTHMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Asthma drug trial halted early: RPT193 fails to show promise
Disease control TerminatedThis study tested an experimental drug called RPT193 in 38 adults with moderate-to-severe asthma that was not fully controlled by standard inhalers. The goal was to see if RPT193 could prevent asthma attacks and improve lung function. However, the trial was terminated early, mean…
Matched conditions: ASTHMA
Phase: PHASE2 • Sponsor: RAPT Therapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 05:03 UTC
-
Experimental asthma pill shows promise, but study halted early
Disease control TerminatedThis study tested an oral drug called dexpramipexole in over 1,000 people with severe eosinophilic asthma, a type of asthma linked to high levels of certain white blood cells. The goal was to see if the drug could reduce serious asthma attacks over 52 weeks when added to standard…
Matched conditions: ASTHMA
Phase: PHASE3 • Sponsor: Areteia Therapeutics • Aim: Disease control
Last updated May 26, 2026 04:36 UTC
-
Asthma drug trial halted midway: what happened?
Disease control TerminatedThis study tested a daily pill called dexpramipexole in 654 people with severe eosinophilic asthma, a type of asthma linked to high levels of certain white blood cells. The goal was to see if the drug could reduce serious asthma attacks over 52 weeks. The trial was terminated ear…
Matched conditions: ASTHMA
Phase: PHASE3 • Sponsor: Areteia Therapeutics • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
Mucus-Targeting inhaler tested for lung disease – study stopped early
Disease control TerminatedThis study tested an inhaled drug called ARO-MUC5AC in healthy people and those with asthma or COPD. The goal was to see if it was safe and could improve lung function by reducing mucus. The study was terminated early, so results are limited.
Matched conditions: ASTHMA
Phase: PHASE1, PHASE2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
Asthma pill for kids shows promise, but study cut short
Symptom relief TerminatedThis study tested a chewable tablet called fevipiprant in children aged 6 to 12 with asthma. The goal was to measure how the drug moves through the body and check its safety. Only 11 children took part before the study was stopped early.
Matched conditions: ASTHMA
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Symptom relief
Last updated May 22, 2026 14:03 UTC
-
Asthma mucus study fizzles: NAC mist trial halted early
Symptom relief TerminatedThis study tested a 20% n-acetylcysteine (NAC) mist to help clear mucus in people with moderate-to-severe asthma. Participants received either NAC or a placebo for two weeks, then switched. The trial was stopped early after enrolling only 4 people, so no clear conclusions can be …
Matched conditions: ASTHMA
Phase: PHASE4 • Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated May 20, 2026 11:57 UTC
-
Scientists probe hidden causes of asthma Flare-Ups
Knowledge-focused TerminatedThis study looked at what causes sudden, severe asthma attacks in adults aged 18 to 75. Researchers measured the thickness and stickiness of mucus from patients having an asthma attack to better understand the disease and how inhaled steroids work. The goal was to find new ways t…
Matched conditions: ASTHMA
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated May 26, 2026 05:04 UTC
-
Gene clue could unlock better asthma care for kids
Knowledge-focused TerminatedThis study looked at whether a specific gene (PDE4) affects how children with asthma respond to the rescue inhaler salbutamol. Researchers planned to compare lung function changes before and after the medication in children aged 6 to 18 with persistent asthma. The goal was to fin…
Matched conditions: ASTHMA
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated May 26, 2026 05:04 UTC
-
Preterm Tots' lungs under the microscope
Knowledge-focused TerminatedThis study followed 152 children aged 3 to 5 years to see how being born early (before 37 weeks) affects lung function. Researchers measured breathing using special tests and checked for signs of asthma and allergies. The goal was to learn more, not to test a new treatment.
Matched conditions: ASTHMA
Sponsor: Stefania La Grutta, MD • Aim: Knowledge-focused
Last updated May 26, 2026 05:03 UTC
-
Tiny study scans bones of steroid users for hidden damage
Knowledge-focused TerminatedThis study aimed to see if new CT scan methods could detect changes in bone density, structure, and marrow fat in people taking oral steroids for severe asthma. Researchers planned to compare steroid users to a control group, but the study was stopped early and only enrolled 2 pa…
Matched conditions: ASTHMA
Sponsor: University of Iowa • Aim: Knowledge-focused
Last updated May 26, 2026 04:37 UTC